Showing 1 to 2 of 2 results
CityU has contributed to the development of a new molecular classification system for colorectal cancer with highly significant potential for treatment and prognosis.
CityU and Guangzhou Pharmaceutical Holdings Limited (GPHL) signed a framework agreement and announced the formation of a strategic alliance.